Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucosyl hesperidin dosing in primary biliary cholangitis
jRCTs051210210Completed
- Sponsor
- Nara Medical University
- Start
- Jun 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of α-glucosyl hesperidin in primary biliary cholangitis (PBC) (2 arms), sponsored by Nara Medical University. Started Jun 2022; status: completed.
02
Drugs
α-glucosyl hesperidin
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on jRCTs051210210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051210210.